坦克结合激酶1
IκB激酶
激酶
化学
丝氨酸
磷酸化
苏氨酸
丝氨酸苏氨酸激酶
癌症研究
细胞生物学
蛋白激酶结构域
蛋白激酶A
信号转导
生物化学
MAP激酶激酶激酶
NF-κB
生物
基因
突变体
作者
Julien Lefranc,Volker Schulze,R.C. Hillig,Hans Briem,Florian Prinz,Anne Mengel,Tobias Heinrich,J Bálint,Srinivasan Rengachari,Horst Irlbacher,Detlef Stöckigt,Ulf Bömer,Benjamin Bader,Stefan Gradl,Carl F. Nising,Franz von Nussbaum,Dominik Mumberg,Daniel Panne,Antje M. Wengner
标识
DOI:10.1021/acs.jmedchem.9b01460
摘要
The serine/threonine kinase TBK1 (TANK-binding kinase 1) and its homologue IKKε are noncanonical members of the inhibitor of the nuclear factor κB (IκB) kinase family. These kinases play important roles in multiple cellular pathways and, in particular, in inflammation. Herein, we describe our investigations on a family of benzimidazoles and the identification of the potent and highly selective TBK1/IKKε inhibitor BAY-985. BAY-985 inhibits the cellular phosphorylation of interferon regulatory factor 3 and displays antiproliferative efficacy in the melanoma cell line SK-MEL-2 but showed only weak antitumor activity in the SK-MEL-2 human melanoma xenograft model.
科研通智能强力驱动
Strongly Powered by AbleSci AI